Advertisement

Cost of illness (COI) of type-II diabetes mellitus in Shillong, Meghalaya

  • T. KhongrangjemEmail author
  • Sameer Phadnis
  • Sumit Kumar
Original Article
  • 50 Downloads

Abstract

This study aimed at contributing to the evidence base of economic burden caused due to type-II DM. The data were obtained from the 158 diabetics from the three tertiary hospitals in Shillong, Meghalaya, during January–March 2017 with the use of a semi-structured questionnaire. The information received was cross-checked with the medical records from the finance department. Patients comprised of 86 (54.4%) females and 72 (45.6%) males. The individuals under the age group of 56–65 were 49 (31%). The total median cost of illness per month was Rs. 5375 (2524–18,968) which was made up of 70.92% direct cost and 29.08% indirect cost. 58.2% respondents used their savings for getting treatment. The cost of care is high and comparable to cost in other countries. An improved understanding of COI of type-II DM will help in informing and motivating the policy and health decision makers which will reduce the national burden of this disease.

Keywords

Cost of illness Type-II diabetes mellitus Shillong Meghalaya 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in the study involving human participants were in accordance with the Ethical standards of the Institutional Ethics Committee of Kasturba Medical College and Kasturba Hospital, Manipal bearing IEC project number: 789/2016.

Informed consent

Prior information on the study objectives was given and informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007;125:217–30.Google Scholar
  2. 2.
    Huizinga MM, Rothman RL. Addressing the diabetes pandemic: a comprehensive approach. Indian J Med Res. 2006;124:481–4.Google Scholar
  3. 3.
    Sicree R, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance. In: Gan D, editor. Diabetes atlas. International Diabetes Federation. 3rd ed. Belgium: International Diabetes Federation; 2006. p. 15–103.Google Scholar
  4. 4.
    Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.CrossRefGoogle Scholar
  5. 5.
    Ramachandran A. Current scenario of diabetes in India. J Diabetes. 2009;1:18–28.CrossRefGoogle Scholar
  6. 6.
    Ali MK, Narayan KM. Innovative research for equitable diabetes care in India. Diabetes Res Clin Pract. 2009;86:155–67.CrossRefGoogle Scholar
  7. 7.
    Syiem D, Lyngdoh W, Warjri P, Tariang D, Dkhar A, Diengdoh AMR. Prevalence of diabetes amongst the Khasi and Jaintia population of Meghalaya. NEHU. Journal. 2012. http://dspace.nehu.ac.in/handle/1/7722.
  8. 8.
    Kessler RC, Petukhova M, McInnes K, Ustün TB. Content and Scoring Rules for the WHO HPQ Absenteeism and Presenteeism Questions. Boston (MA): Harvard Medical School; 2007.Google Scholar
  9. 9.
    Riewpaiboon A, Chatterjee S, Piyauthakit P. Cost analysis for efficient management: diabetes treatment at a public district hospital in Thailand. Int J Pharm Pract. 2011;19:342–9.CrossRefGoogle Scholar
  10. 10.
    Grover S, Avasthi A, Bhansali A, Chakrabarti S, Kulhara P: Cost of ambulatory care of diabetes mellitus: a study from north India. Postgrad Med J. 2005;81(956):391–5.  https://doi.org/10.1136/pgmj.2004.024299.
  11. 11.
    Hex N, Barlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012;29(7):855–62.CrossRefGoogle Scholar
  12. 12.
    Barcelo A, Aedo C, Rajpathak S and Robles S. The cost of diabetes in Latin America and the Caribbean. Bull World Health Organ. 2003;81(1):19–27.Google Scholar
  13. 13.
    Jo C. Cost-of-illness studies: concepts, scopes and methods. Clin Mol Hepatol. 2014;20(4):327–37.CrossRefGoogle Scholar
  14. 14.
    Henriksson F, Agardh CD, Berne C, Bolinder J, Lönnqvist F, Stenström P, et al. Direct medical costs for patients with type 2 diabetes in Sweden. J Int Med. 2000;248(5):387–96.Google Scholar
  15. 15.
    NIDA (2010). Comorbidity: addiction and other mental illness. Retrieved April 9, 2017, from https://www.drugabuse.gov/publications/research-reports/comorbidity-addiction-other-mental-illnessesbehaviors.
  16. 16.
    Viswanathan V, Tharkar S, Devarajan A, Kumpatla S. The socioeconomics of a developing country: a population based cost of illness study. Diab Res Clin Pract. 2010;89:334–40.CrossRefGoogle Scholar
  17. 17.
    Anderson Carl R. Locus of control, coping and performance in a stress setting: a longitudinal study. J Appl Psychol. 1977;62:446–51. Google ScholarCrossRefGoogle Scholar
  18. 18.
    Narayan KM, Zhang P, Williams D, Engelau M, Imperatore G. How should developing countries manage diabetes. CMAJ. 2006;175:733–43.CrossRefGoogle Scholar
  19. 19.
    The Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. JAMA 1996;276:1409–15.Google Scholar
  20. 20.
    Chatterjee S, Riewpaiboon A, Piyauthakit P, Riewpaiboon W, Bonpaijit K, Panpuwong N, Acharvanuntagal V. Cost of diabetes and its complications in Thailand: A complete picture of economic burden. Health Soc Care Community. 2011;119(3):289–98.Google Scholar
  21. 21.
    American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. Diabetes Care. 1997–98; 21:296-309.  https://doi.org/10.2337/diacare.21.2.296.
  22. 22.
    Dawson KG, Gomes D, Gerstein H, Blanchard JF, Kahler KH. The economic cost of diabetes in Canada, 1998. Diabetes Care. 2002;25(8):1303–7.CrossRefGoogle Scholar
  23. 23.
    Rc E, Javitt JC, Herman WH, Dasbach EJ, Zbrozek AS, Dong F, et al. Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care. 1991;20:725–44.Google Scholar

Copyright information

© Research Society for Study of Diabetes in India 2018

Authors and Affiliations

  1. 1.Prasanna School of Public HealthManipal Academy of Higher EducationManipalIndia

Personalised recommendations